Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.

Edoardo CriminiGiulia TiniPaolo TarantinoLiliana AscioneMatteo RepettoPaolo BeriaAlberto RanghieroAntonio MarraCarmen BelliCarmen CriscitielloAngela EspositoElena Guerini RoccoMassimo C P BarberisLuca MazzarellaCurigliano Giuseppe

Published in: The oncologist (2023)

The median distance to be travelled to the nearest trial was generally acceptable for patients, and trials availability is increasing. Nevertheless, many areas are still lacking trials, so efforts are required to increase and homogenize the possibilities to be enrolled in clinical trials for Italian patients with cancer.

Keyphrases

clinical trial
phase ii
end stage renal disease
phase iii
ejection fraction
newly diagnosed
quality improvement
prognostic factors
gene expression
randomized controlled trial